<DOC>
	<DOCNO>NCT02654782</DOCNO>
	<brief_summary>Looking individual total fluid volume alveolar-arterial gradient 5 % human albumin Lactated Ringer 's perioperative cardiac surgical patient . Our hypothesis individual total fluid volume alveolar-arterial gradient less 5 % human albumin compare Lactated Ringer 's perioperative cardiac surgical patient .</brief_summary>
	<brief_title>Lactated Ringer 's Versus 5 % Human Albumin : Cardiac Surgical Patients</brief_title>
	<detailed_description>Following IRB approval write informed patient consent , 40 elective , cardiac surgical patient randomize two different fluid therapy regimen , 5 % human albumin Lactated Ringer 's , begin intraoperative period 6 hour intensive care unit . Providers patient blind fluid administer operating room intensive care unit . The primary outcome measure total volume 5 % human albumin Lactated Ringer 's give study period maintain specified hemodynamic guideline . Hemodynamic instability define accord patient 's stipulated baseline parameter . Fluid administer request provider operate room intensive care unit compliance perioperative fluid algorithm . Outcome measure hemodynamic instability include systolic diastolic blood pressure ; mean arterial pressure , central venous pressure , cardiac index , urine output , vasopressor use . Alveolar-arterial gradient assess two choice fluid determine relationship fluid choice duration intubation intensive care unit . Blinding fluid therapy do group patient detection bias towards one fluid may appreciate .</detailed_description>
	<criteria>Adults Nonpregnant female patient Elective surgery Aspirin , heparin , warfarin preoperatively accept Exclusionary Criteria : Previous sternotomy Emergency surgery Combined procedure ( vascular thoracic operation ) Congenital repair Hypothermic CPB &lt; 28C Serum creatinine 1.5 mg/dL Dialysis dependent renal failure Neurologic injury event within 30 day ( include TIA ) Cerebrovascular accident significant residual neurologic deficit Severe COPD FEV1 &lt; 45 % predict Home oxygen use Previous difficult intubation Acute normovolemic blood conservation technique Liver disease serum AST &gt; 31 U/L Circulatory arrest Thrombolysis Preexisting clot disorder Platelet receptor GPIIb/IIIa antagonist medication receive within 48 hour Steroids EF &lt; 40 % Intraaortic balloon pump Ongoing congestive heart failure Ventricular assist device Total heart Pregnant woman Adults lack capacity consent Any patient initially enrol study end intraaortic balloon pump , leave ventricular assist device , extracorporeal membrane oxygenation eliminate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>